Wed., Jan. 20 | ONLINE

Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Registration is Closed
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Time & Location

Jan. 20, 7:00 p.m. – 9:00 p.m. EST
ONLINE

About the Event

About this Event

CHEP+ Clinical Practice Guidelines Program

Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Wed January 20, 2021, • 7:00-9:00 PM ET

Presented by: Dr. Sheldon Tobe MD, FRCPC, MScCH (HPTE), FACP, FAHA

Dr.  Tobe is a specialist in Hypertension and Nephrology, Division of  Nephrology, Sunnybrook Health Sciences Centre, and is the University of  Toronto Postgraduate Fellowship Director – Nephrology. He is a Professor  in the Faculty of Medicine, University of Toronto and Northern Ontario  School of Medicine (NOSM).

LEARNING OBJECTIVES

Upon completion of this case study, participants should be able to:

  • Describe the rationale for anticoagulation of non-valvular atrial fibrillation
  • Describe the effect on outcomes of non-valvular atrial fibrillation with CKD
  • Describe the management of patients with CKD and non-valvular atrial fibrillation

Accreditation: This Group Learning program has been certified by the Canadian College  of Family Physicians for up to 6 Mainpro+ credits for the 2-hour  presentation including a practice reflection survey to be completed at 6  weeks post-session.

Registration is Closed

Share This Event